QRG Capital Management Inc. Buys 1,532 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

QRG Capital Management Inc. raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 2.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 72,842 shares of the medical equipment provider's stock after purchasing an additional 1,532 shares during the quarter. QRG Capital Management Inc.'s holdings in Intuitive Surgical were worth $38,020,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the business. Massachusetts Financial Services Co. MA bought a new stake in Intuitive Surgical in the 3rd quarter worth about $558,807,000. Proficio Capital Partners LLC boosted its holdings in shares of Intuitive Surgical by 89,098.8% in the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider's stock worth $495,845,000 after buying an additional 948,902 shares during the last quarter. FMR LLC raised its position in Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider's stock worth $5,389,765,000 after acquiring an additional 838,793 shares during the period. Wilmington Savings Fund Society FSB raised its position in Intuitive Surgical by 15,322.2% in the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider's stock worth $272,980,000 after acquiring an additional 552,058 shares during the period. Finally, Strategic Financial Concepts LLC grew its position in shares of Intuitive Surgical by 50,740.8% during the 4th quarter. Strategic Financial Concepts LLC now owns 312,671 shares of the medical equipment provider's stock valued at $163,202,000 after acquiring an additional 312,056 shares during the period. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Stock Performance

ISRG stock traded up $9.38 during trading on Friday, hitting $573.15. 2,399,758 shares of the company traded hands, compared to its average volume of 1,733,598. The company has a 50-day moving average of $569.87 and a 200-day moving average of $528.64. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The firm has a market capitalization of $204.14 billion, a PE ratio of 89.42, a P/E/G ratio of 5.85 and a beta of 1.39.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Myriam Curet sold 2,401 shares of the company's stock in a transaction on Thursday, February 27th. The shares were sold at an average price of $581.00, for a total value of $1,394,981.00. Following the completion of the transaction, the executive vice president now directly owns 353 shares in the company, valued at approximately $205,093. This represents a 87.18 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the business's stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 8,077 shares of company stock valued at $4,620,025 in the last quarter. Insiders own 0.80% of the company's stock.

Analyst Ratings Changes

Several equities analysts have weighed in on the company. Jefferies Financial Group increased their price objective on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Piper Sandler reaffirmed an "overweight" rating and set a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Citigroup lifted their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a "buy" rating in a research note on Friday, January 24th. BTIG Research upped their price target on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a "buy" rating in a research note on Tuesday, November 26th. Finally, Morgan Stanley raised shares of Intuitive Surgical from an "equal weight" rating to an "overweight" rating and boosted their target price for the company from $522.00 to $650.00 in a report on Monday, December 2nd. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.